发明名称 METHOD FOR DIAGNOSIS OF ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, DIAGNOSTIC AGENT, THERAPEUTIC AGENT, AND SCREENING METHOD FOR SAID AGENTS
摘要 It is now understood that, from the preclinical stage of Alzheimer's disease, abnormalities in spine formation and the like occur due to worsening phosphorylation of MARCKS and the like, thereby leading to the onset of the disease in the patient. It is also understood that PCK and the like are responsible for phosphorylation of MARCKS and the like, and that b-raf participates in phosphorylation of the tau protein, which is important for the advance of Alzheimer's disease. Accordingly, it was discovered that these proteins are useful target molecules for the diagnosis and treatment of Alzheimer's disease. It is also now understood that, in the preclinical stage of frontotemporal lobar degeneration as well, a decrease in the number of spines and the like occurs due to a worsening of phosphorylation of b-RAF, thereby leading to the onset of the disease in the patient. Accordingly, it was discovered that b-RAF is a useful target molecule for the diagnosis and treatment of frontotemporal lobar degeneration.
申请公布号 WO2015099094(A1) 申请公布日期 2015.07.02
申请号 WO2014JP84424 申请日期 2014.12.25
申请人 NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL ANDDENTAL UNIVERSITY 发明人 OKAZAWA HITOSHI
分类号 G01N33/68;A61K45/00;A61P25/28;C12Q1/48;G01N33/15;G01N33/50 主分类号 G01N33/68
代理机构 代理人
主权项
地址